MEENA DATTA, global co-leader of the firm’s Healthcare practice and member of the global Life Sciences team, manages key strategic matters for life sciences and healthcare companies throughout the world. Meena focuses on regulatory counseling and compliance matters on all aspects of healthcare law that impact pharmaceutical and medical device manufacturers; clinical diagnostic laboratories; private equity firms focused on healthcare; healthcare and digital health companies; and innovators and disruptors. Meena has helped clients solve critical business problems involving healthcare reform; fraud and abuse compliance, particularly in the design and execution of arrangements in compliance with the Federal Anti-Kickback Statute; pharmaceutical government price reporting and state drug price transparency laws; federal healthcare program coverage and reimbursement issues; healthcare compliance programs, including drafting policies and procedures, counseling on implementation issues, and conducting audits and internal reviews; market access contracting and programs; HIPAA and HITECH implementation and compliance; and the Sunshine Act and similar state laws.
Meena is recognized as a top healthcare lawyer in the U.S. She was recognized in the 2013 and 2016 editions of The Legal 500 U.S., which reported in its 2013 edition that Meena is a “pricing and fraud and abuse specialist.” Meena has been recommended in the area of Regulatory Law by Chambers 2015 and 2016, where she was praised as having “a great depth of subject matter expertise which spans various health law industries.” She has also been named as a “Rising Star” in Law360 (2018) and the Euromoney LMG 2015 Guide.
In addition, Meena is highly experienced in representing small and emerging biopharmaceutical and biotechnology companies. Over the years, she has served as lead healthcare counsel in over 20 new product launches, where she has effectively partnered with in-house counsel and business teams on a wide-variety of critical business issues including distribution and market access models, value-based arrangements, government price reporting and customer interactions in the field. She also adds significant breadth of knowledge across various settings of care to help her clients establish effective compliance programs and compliant patient assistance programs.
Meena also regularly leads regulatory due diligences for private equity firms and life sciences clients. Meena effectively and efficiently manages Sidley’s regulatory due diligence teams on a global scale, making key recommendations on areas of potential risk and providing pragmatic advice to address issues that may arise in regulatory diligence.
Meena received her B.A. from Brown University and her J.D. from the University of Chicago Law School. Meena has spoken at a variety of national and state conferences, including BIO and AdvaMed. Topics she has covered include the patient assistance programs, value-based contracting, the Sunshine Act, pharmaceutical and medical device manufacturer enforcement actions, the Medicaid Drug Rebate Program, and HIPAA. She has lectured for a Healthcare Management course at Loyola University’s Chicago Graduate School of Business and the Seton Hall Law School Healthcare Compliance Certificate Program. Meena is proud member of the Board of Directors of the March of Dimes, Chicago Chapter.
Admissions & Certifications
- U.S. District Court, N.D. of Illinois - General
- The University of Chicago Law School, J.D., 2003
- Brown University, B.A., 2000